ENYO Pharma is a biopharmaceutical company based in Lyon, France.
ENYO Pharma has raised $6.9M in total funding. The most recent round was Series C. The last funding was announced in June 2025.
ENYO Pharma's investors include Bpifrance, OrbiMed, Sofinnova Partners, Andera Partners, Sofinnova Investments.
ENYO Pharma is headquartered in Lyon, France.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
ENYO Pharma is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ENYO Pharma — Funding & Investors." VCBacked, June 12, 2025, https://www.vcbacked.co/company/enyo-pharma. Accessed September 4, 2026.
VCBacked. (2025). ENYO Pharma — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/enyo-pharma
{{cite web |title=ENYO Pharma — Funding & Investors |url=https://www.vcbacked.co/company/enyo-pharma |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated